Epsilon Healthcare Ltd Market Cap ($5.51 Million)
Market Cap & Net Worth: Epsilon Healthcare Ltd (EPN)
Epsilon Healthcare Ltd market cap. Epsilon Healthcare Ltd (AU:EPN) has a market capitalization of $5.51 Million (AU$7.78 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28291 globally and #1450 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epsilon Healthcare Ltd's stock price AU$0.02 by its total outstanding shares 389104011 (389.10 Million). Also see cash flow conversion of Epsilon Healthcare Ltd for how efficiently the company converts equity into cash flow.
Epsilon Healthcare Ltd Market Cap History (2017–2026)
Epsilon Healthcare Ltd market cap history from 2017 to 2026. Data shows change from $187.21 Million to $5.51 Million (-27.11% CAGR). Check current stock price of Epsilon Healthcare Ltd for real-time trading data and today's change.
Epsilon Healthcare Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epsilon Healthcare Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Epsilon Healthcare Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.97x
Epsilon Healthcare Ltd's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $187.21 Million | $1.90 Million | -$2.56 Million | 98.38x | N/A |
| 2018 | $128.02 Million | $2.66 Million | -$8.61 Million | 48.05x | N/A |
| 2019 | $104.62 Million | $4.79 Million | -$11.68 Million | 21.83x | N/A |
| 2020 | $64.70 Million | $7.36 Million | -$10.95 Million | 8.79x | N/A |
| 2021 | $19.55 Million | $5.50 Million | -$8.91 Million | 3.56x | N/A |
| 2022 | $6.88 Million | $7.11 Million | -$13.29 Million | 0.97x | N/A |
| 2023 | $6.61 Million | $6.65 Million | -$1.09 Million | 0.99x | N/A |
| 2024 | $6.61 Million | $5.60 Million | -$3.25 Million | 1.18x | N/A |
| 2025 | $9.09 Million | $9.39 Million | -$1.28 Million | 0.97x | N/A |
Competitor Companies of EPN by Market Capitalization
Companies near Epsilon Healthcare Ltd in the global market cap rankings as of November 7, 2026. Also see EPN total asset value for a full breakdown of the balance sheet.
Key companies related to Epsilon Healthcare Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Epsilon Healthcare Ltd (2017–2026)
Market capitalization of Epsilon Healthcare Ltd from 2017 to today. Between 2017 and today, Epsilon Healthcare Ltd's market cap moved from $187.21 Million to $ 5.51 Million, with a yearly change of -27.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$5.51 Million | -39.39% |
| 2025 | AU$9.09 Million | +37.50% |
| 2024 | AU$6.61 Million | 0.00% |
| 2023 | AU$6.61 Million | -4.00% |
| 2022 | AU$6.88 Million | -64.79% |
| 2021 | AU$19.55 Million | -69.79% |
| 2020 | AU$64.70 Million | -38.16% |
| 2019 | AU$104.62 Million | -18.28% |
| 2018 | AU$128.02 Million | -31.62% |
| 2017 | AU$187.21 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Epsilon Healthcare Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.51 Million USD |
| MoneyControl | $5.51 Million USD |
| MarketWatch | $5.51 Million USD |
| marketcap.company | $5.51 Million USD |
| Reuters | $5.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Epsilon Healthcare Ltd
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more